For example, miR-101 suppresses the proliferation and migration of HCC cells and tumors through targeting HGF/c-Met, Girdin, SOX9 and TGF-β in in vitro and in vivo trials (Cao et al., 2016; Yang et al., 2016; Yan et al., 2018; Liu et al., 2019). The gene discussed is MET; the disease is hepatocellular carcinoma.